Patent · US Active

Reduced-viscosity concentrated protein formulations

US8703126B2 · kind B2 · utility

50Cited by

39References

24Claims

0Family size

Assignees

Genentech, Inc. · US
Novartis AG · CH

Inventors

Jun Liu · South San Francisco, US
Steven J. Shire · San Mateo, US

Key dates

Filing date	Nov 29, 2011
Grant date	Apr 22, 2014
Priority date	—
Expiry date	Nov 29, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/505
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application concerns concentrated protein formulations with reduced viscosity, which are particularly suitable for subcutaneous administration. The application further concerns a method for reducing the viscosity of concentrated protein formulations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.